{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T02:26:51Z","timestamp":1790130411091,"version":"4.0.1"},"reference-count":88,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Immunology"],"published-print":{"date-parts":[[2020,2]]},"DOI":"10.1016\/j.clim.2019.108325","type":"journal-article","created":{"date-parts":[[2019,12,11]],"date-time":"2019-12-11T03:04:48Z","timestamp":1576033488000},"page":"108325","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":41,"special_numbering":"C","title":["Childhood GPA, EGPA, and MPA"],"prefix":"10.1016","volume":"211","author":[{"given":"Mehul","family":"Jariwala","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronald M.","family":"Laxer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2013","key":"10.1016\/j.clim.2019.108325_bb0005","first-page":"1","article-title":"International Chapel Hill Consensus Conference Nomenclature of Vasculitides","volume":"65","author":"Jennette","year":"2012","journal-title":"Arthritis Rheum."},{"issue":"2015","key":"10.1016\/j.clim.2019.108325_bb0010","article-title":"Brief report: childhood-onset systemic necrotizing vasculitides: long-term data from the French vasculitis study group registry","volume":"67","author":"Iudici","year":"1959","journal-title":"Arthritis Rheum."},{"issue":"Suppl. 1","key":"10.1016\/j.clim.2019.108325_bb0015","doi-asserted-by":"crossref","first-page":"i14","DOI":"10.1093\/ndt\/gfv022","article-title":"Classification, epidemiology and clinical subgrouping of antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis","volume":"30","author":"Watts","year":"2015","journal-title":"Nephrol. Dial. Transplant."},{"key":"10.1016\/j.clim.2019.108325_bb0020","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1093\/rheumatology\/ker454","article-title":"The contrasting epidemiology of granulomatosis with polyangiitis (Wegener's) and microscopic polyangiitis","volume":"51","author":"Watts","year":"2012","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.clim.2019.108325_bb0025","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1007\/s10157-013-0813-9","article-title":"Epidemiology of vasculitides: differences between Japan, Europe and North America","volume":"17","author":"Kobayashi","year":"2013","journal-title":"Clin. Exp. Nephrol."},{"key":"10.1016\/j.clim.2019.108325_bb0030","doi-asserted-by":"crossref","first-page":"2514","DOI":"10.1002\/art.39729","article-title":"Comparing presenting clinical features in 48 children with microscopic polyangiitis to 183 children who have granulomatosis with polyangiitis (Wegener's): an ARChiVe cohort study","volume":"68","author":"Cabral","year":"2016","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.clim.2019.108325_bb0035","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1007\/s00467-019-04228-4","article-title":"Epidemiology and clinical features of childhood-onset anti-neutrophil cytoplasmic antibody-associated vasculitis: a clinicopathological analysis","volume":"34","author":"Hirano","year":"2019","journal-title":"Pediatr. Nephrol."},{"key":"10.1016\/j.clim.2019.108325_bb0040","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1080\/03009742.2017.1412497","article-title":"Epidemiology of primary systemic vasculitis in children: a population-based study from southern Sweden","volume":"47","author":"Mossberg","year":"2018","journal-title":"Scand. J. Rheumatol."},{"issue":"Suppl. 1","key":"10.1016\/j.clim.2019.108325_bb0045","doi-asserted-by":"crossref","first-page":"i104","DOI":"10.1093\/ndt\/gfv011","article-title":"Clinical characteristics and outcomes of childhood-onset ANCA-associated vasculitis: a French nationwide study","volume":"30","author":"Sacri","year":"2015","journal-title":"Nephrol. Dial. Transplant."},{"key":"10.1016\/j.clim.2019.108325_bb0050","first-page":"589","article-title":"The incidence, prevalence and mortality of granulomatosis with polyangiitis in the UK clinical practice research datalink","volume":"56","author":"Pearce","year":"2017","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.clim.2019.108325_bb0055","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1056\/NEJMoa1108735","article-title":"Genetically distinct subsets within ANCA-associated vasculitis","volume":"367","author":"Lyons","year":"2012","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.clim.2019.108325_bb0060","doi-asserted-by":"crossref","first-page":"2457","DOI":"10.1002\/art.38036","article-title":"Association of granulomatosis with polyangiitis (Wegener's) with HLA-DPB1*04 and SEMA6A gene variants: evidence from genome-wide analysis","volume":"65","author":"Xie","year":"2013","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.clim.2019.108325_bb0065","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1046\/j.1365-2249.1999.00969.x","article-title":"Immunogenetic risk factors for anti-neutrophil cytoplasmic antibody (ANCA)-associated systemic vasculitis","volume":"117","author":"Gencik","year":"1999","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.clim.2019.108325_bb0070","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0042783","article-title":"High basal activity of the PTPN22 gain-of-function variant blunts leukocyte responsiveness negatively affecting IL-10 production in ANCA vasculitis","volume":"7","author":"Cao","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.clim.2019.108325_bb0075","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1038\/nrrheum.2014.103","article-title":"Pathogenesis of antineutrophil cytoplasmic autoantibody-mediated disease","volume":"10","author":"Jennette","year":"2014","journal-title":"Nat. Rev. Rheumatol."},{"key":"10.1016\/j.clim.2019.108325_bb0080","doi-asserted-by":"crossref","first-page":"12","DOI":"10.7326\/0003-4819-120-1-199401010-00003","article-title":"Association of chronic nasal carriage of Staphylococcus aureus and higher relapse rates in Wegener granulomatosis","volume":"120","author":"Stegeman","year":"1994","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.clim.2019.108325_bb0085","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1681\/ASN.2016050548","article-title":"Gene-specific DNA methylation changes predict remission in patients with ANCA-associated vasculitis","volume":"28","author":"Jones","year":"2017","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.clim.2019.108325_bb0090","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1038\/nm.1959","article-title":"Netting neutrophils in autoimmune small-vessel vasculitis","volume":"15","author":"Kessenbrock","year":"2009","journal-title":"Nat. Med."},{"key":"10.1016\/j.clim.2019.108325_bb0095","doi-asserted-by":"crossref","first-page":"E9618","DOI":"10.1073\/pnas.1708247114","article-title":"Necroptosis controls NET generation and mediates complement activation, endothelial damage, and autoimmune vasculitis","volume":"114","author":"Schreiber","year":"2017","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.clim.2019.108325_bb0100","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1111\/cei.12654","article-title":"Neutrophil extracellular traps can activate alternative complement pathways","volume":"181","author":"Wang","year":"2015","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.clim.2019.108325_bb0105","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.2353\/ajpath.2009.080458","article-title":"Experimental autoimmune vasculitis: an animal model of anti-neutrophil cytoplasmic autoantibody-associated systemic vasculitis","volume":"174","author":"Little","year":"2009","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.clim.2019.108325_bb0110","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1172\/JCI0215918","article-title":"Antineutrophil cytoplasmic autoantibodies specific for myeloperoxidase cause glomerulonephritis and vasculitis in mice","volume":"110","author":"Xiao","year":"2002","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.clim.2019.108325_bb0115","doi-asserted-by":"crossref","first-page":"4115","DOI":"10.1073\/pnas.87.11.4115","article-title":"Anti-neutrophil cytoplasmic autoantibodies induce neutrophils to degranulate and produce oxygen radicals in vitro","volume":"87","author":"Falk","year":"1990","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.clim.2019.108325_bb0120","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.1002\/art.39637","article-title":"Factors determining the clinical utility of serial measurements of antineutrophil cytoplasmic antibodies targeting proteinase 3","volume":"68","author":"Fussner","year":"2016","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.clim.2019.108325_bb0125","first-page":"S28","article-title":"Two types of myeloperoxidase-antineutrophil cytoplasmic autoantibodies with a high affinity and a low affinity in small vessel vasculitis","volume":"27","author":"Yoshida","year":"2009","journal-title":"Clin. Exp. Rheumatol."},{"key":"10.1016\/j.clim.2019.108325_bb0130","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1186\/ar3362","article-title":"T-helper cells as new players in ANCA-associated vasculitides","volume":"13","author":"Abdulahad","year":"2011","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.clim.2019.108325_bb0135","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1038\/ki.2012.313","article-title":"Circulating complement activation in patients with anti-neutrophil cytoplasmic antibody-associated vasculitis","volume":"83","author":"Gou","year":"2013","journal-title":"Kidney Int."},{"key":"10.1016\/j.clim.2019.108325_bb0140","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1038\/s41584-018-0145-y","article-title":"Pathogenesis and therapeutic interventions for ANCA-associated vasculitis","volume":"15","author":"Nakazawa","year":"2019","journal-title":"Nat. Rev. Rheumatol."},{"key":"10.1016\/j.clim.2019.108325_bb0145","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1038\/nrrheum.2014.98","article-title":"Eosinophils in vasculitis: characteristics and roles in pathogenesis","volume":"10","author":"Khoury","year":"2014","journal-title":"Nat. Rev. Rheumatol."},{"key":"10.1016\/j.clim.2019.108325_bb0150","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1111\/all.12088","article-title":"Eosinophilic granulomatosis with polyangiitis (Churg-Strauss): state of the art","volume":"68","author":"Vaglio","year":"2013","journal-title":"Allergy"},{"key":"10.1016\/j.clim.2019.108325_bb0155","doi-asserted-by":"crossref","first-page":"636","DOI":"10.3389\/fimmu.2016.00636","article-title":"The presence of anti-lactoferrin antibodies in a subgroup of eosinophilic granulomatosis with Polyangiitis patients and their possible contribution to enhancement of neutrophil extracellular trap formation","volume":"7","author":"Shida","year":"2016","journal-title":"Front. Immunol."},{"key":"10.1016\/j.clim.2019.108325_bb0160","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1002\/art.1780330807","article-title":"The American College of Rheumatology 1990 criteria for the classification of Wegener\u2019s granulomatosis","volume":"33","author":"Leavitt","year":"1990","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.clim.2019.108325_bb0165","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1002\/art.1780330806","article-title":"The American College of Rheumatology 1990 criteria for the classification of Churg-Strauss syndrome (allergic granulomatosis and angiitis)","volume":"33","author":"Masi","year":"1990","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.clim.2019.108325_bb0170","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1136\/ard.2009.116657","article-title":"EULAR\/PRINTO\/PRES criteria for Henoch-Schonlein purpura, childhood polyarteritis nodosa, childhood Wegener granulomatosis and childhood Takayasu arteritis: Ankara 2008. Part II: Final classification criteria","volume":"69","author":"Ozen","year":"2010","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.clim.2019.108325_bb0175","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1136\/ard.2006.054593","article-title":"Development and validation of a consensus methodology for the classification of the ANCA-associated vasculitides and polyarteritis nodosa for epidemiological studies","volume":"66","author":"Watts","year":"2007","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.clim.2019.108325_bb0180","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.3899\/jrheum.111352","article-title":"Increased sensitivity of the European medicines agency algorithm for classification of childhood granulomatosis with polyangiitis","volume":"39","author":"Uribe","year":"2012","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.clim.2019.108325_bb0185","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1097\/00005792-198403000-00001","article-title":"Systemic vasculitis with asthma and eosinophilia: a clinical approach to the Churg-Strauss syndrome","volume":"63","author":"Lanham","year":"1984","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.clim.2019.108325_bb0190","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1186\/s13023-016-0523-y","article-title":"Childhood-onset granulomatosis with polyangiitis and microscopic polyangiitis: systematic review and meta-analysis","volume":"11","author":"Iudici","year":"2016","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/j.clim.2019.108325_bb0195","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.autrev.2017.11.014","article-title":"Childhood- versus adult-onset ANCA-associated vasculitides: a nested, matched case-control study from the French Vasculitis Study Group Registry","volume":"17","author":"Iudici","year":"2018","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.clim.2019.108325_bb0200","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1002\/art.22774","article-title":"Clinical features and outcome of pediatric Wegener\u2019s granulomatosis","volume":"57","author":"Akikusa","year":"2007","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.clim.2019.108325_bb0205","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/1546-0096-12-18","article-title":"Clinical features of childhood granulomatosis with polyangiitis (wegener's granulomatosis)","volume":"12","author":"Bohm","year":"2014","journal-title":"Pediatr. Rheumatol. Online J."},{"issue":"Suppl. 103","key":"10.1016\/j.clim.2019.108325_bb0210","first-page":"202","article-title":"Clinical course and outcomes of childhood-onset granulomatosis with polyangiitis","volume":"35","author":"James","year":"2017","journal-title":"Clin. Exp. Rheumatol."},{"key":"10.1016\/j.clim.2019.108325_bb0215","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1186\/s13052-017-0364-x","article-title":"ANCA-associated vasculitis in childhood: recent advances","volume":"43","author":"Calatroni","year":"2017","journal-title":"Ital. J. Pediatr."},{"key":"10.1016\/j.clim.2019.108325_bb0220","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1681\/ASN.V1271493","article-title":"Antineutrophil cytoplasmic autoantibody-associated glomerulonephritis in children","volume":"12","author":"Hattori","year":"2001","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.clim.2019.108325_bb0225","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1002\/(SICI)1099-0496(200005)29:5<382::AID-PPUL7>3.0.CO;2-D","article-title":"Pulmonary renal syndrome in childhood: a report of twenty-one cases and a review of the literature","volume":"29","author":"von Vigier","year":"2000","journal-title":"Pediatr. Pulmonol."},{"key":"10.1016\/j.clim.2019.108325_bb0230","doi-asserted-by":"crossref","first-page":"1712","DOI":"10.3899\/jrheum.131300","article-title":"Clinical and pathological features of microscopic polyangiitis in 20 children","volume":"41","author":"Sun","year":"2014","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.clim.2019.108325_bb0235","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1136\/adc.85.5.427","article-title":"The significance of antineutrophil cytoplasmic antibody in microscopic polyangitis and classic polyarteritis nodosa","volume":"85","author":"Bakkaloglu","year":"2001","journal-title":"Arch. Dis. Child."},{"key":"10.1016\/j.clim.2019.108325_bb0240","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1007\/s00467-006-0028-3","article-title":"The clinical features of anti-neutrophil cytoplasmic antibody-associated systemic vasculitis in Chinese children","volume":"21","author":"Yu","year":"2006","journal-title":"Pediatr. Nephrol."},{"issue":"Suppl. 1","key":"10.1016\/j.clim.2019.108325_bb0245","doi-asserted-by":"crossref","first-page":"i113","DOI":"10.1093\/ndt\/gfv016","article-title":"Favourable renal survival in paediatric microscopic polyangiitis: efficacy of a novel treatment algorithm","volume":"30","author":"Basu","year":"2015","journal-title":"Nephrol. Dial. Transplant."},{"key":"10.1016\/j.clim.2019.108325_bb0250","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1097\/BOR.0000000000000015","article-title":"Eosinophilic granulomatosis with polyangiitis (Churg-Strauss): evolutions in classification, etiopathogenesis, assessment and management","volume":"26","author":"Mahr","year":"2014","journal-title":"Curr. Opin. Rheumatol."},{"key":"10.1016\/j.clim.2019.108325_bb0255","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/S0190-9622(97)80125-9","article-title":"Cutaneous manifestations of Churg-Strauss syndrome: a clinicopathologic correlation","volume":"37","author":"Davis","year":"1997","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1016\/j.clim.2019.108325_bb0260","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1093\/rheumatology\/kew029","article-title":"Eosinophilic granulomatosis with polyangiitis in childhood: retrospective experience from a tertiary referral centre in the UK","volume":"55","author":"Eleftheriou","year":"2016","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.clim.2019.108325_bb0265","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.semarthrit.2008.05.004","article-title":"Churg-Strauss syndrome in childhood: a systematic literature review and clinical comparison with adult patients","volume":"39","author":"Zwerina","year":"2009","journal-title":"Semin. Arthritis Rheum."},{"key":"10.1016\/j.clim.2019.108325_bb0270","doi-asserted-by":"crossref","first-page":"929","DOI":"10.3899\/jrheum.120808","article-title":"Childhood-onset eosinophilic granulomatosis with polyangiitis (formerly Churg-Strauss syndrome): a contemporary single-center cohort","volume":"40","author":"Gendelman","year":"2013","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.clim.2019.108325_bb0275","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.1002\/ppul.24089","article-title":"Eosinophilic granulomatosis with polyangiitis in children: data from the French RespiRare(R) cohort","volume":"53","author":"Fina","year":"2018","journal-title":"Pediatr. Pulmonol."},{"key":"10.1016\/j.clim.2019.108325_bb0280","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.1136\/annrheumdis-2012-202111","article-title":"Disease activity assessment in childhood vasculitis: development and preliminary validation of the Paediatric Vasculitis Activity Score (PVAS)","volume":"72","author":"Dolezalova","year":"2013","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.clim.2019.108325_bb0285","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1002\/art.1780400222","article-title":"Development and initial validation of the vasculitis damage index for the standardized clinical assessment of damage in the systemic vasculitides","volume":"40","author":"Exley","year":"1997","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.clim.2019.108325_bb0290","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1136\/annrheumdis-2014-eular.5893","article-title":"SAT0286 paediatric vasculitis damage index: a new tool for standardised disease assessment","volume":"73","author":"Dolezalova","year":"2014","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.clim.2019.108325_bb0295","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1002\/art.40112","article-title":"Early outcomes in children with antineutrophil cytoplasmic antibody-associated vasculitis","volume":"69","author":"Morishita","year":"2017","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.clim.2019.108325_bb0300","doi-asserted-by":"crossref","first-page":"97","DOI":"10.3899\/jrheum.150376","article-title":"CanVasc recommendations for the management of antineutrophil cytoplasm antibody-associated vasculitides","volume":"43","author":"McGeoch","year":"2016","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.clim.2019.108325_bb0305","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1136\/annrheumdis-2016-209133","article-title":"EULAR\/ERA-EDTA recommendations for the management of ANCA-associated vasculitis","volume":"75","author":"Yates","year":"2016","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.clim.2019.108325_bb0310","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1093\/rheumatology\/key322","article-title":"European consensus-based recommendations for the diagnosis and treatment of rare paediatric vasculitides - the SHARE initiative","volume":"58","author":"de Graeff","year":"2019","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.clim.2019.108325_bb0315","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1136\/ard.2006.062711","article-title":"EULAR recommendations for conducting clinical studies and\/or clinical trials in systemic vasculitis: focus on anti-neutrophil cytoplasm antibody-associated vasculitis","volume":"66","author":"Hellmich","year":"2007","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.clim.2019.108325_bb0320","doi-asserted-by":"crossref","first-page":"2299","DOI":"10.1002\/art.11075","article-title":"Limited versus severe Wegener's granulomatosis: baseline data on patients in the Wegener's granulomatosis etanercept trial","volume":"48","author":"Stone","year":"2003","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.clim.2019.108325_bb0325","doi-asserted-by":"crossref","first-page":"670","DOI":"10.7326\/0003-4819-150-10-200905190-00004","article-title":"Pulse versus daily oral cyclophosphamide for induction of remission in antineutrophil cytoplasmic antibody-associated vasculitis: a randomized trial","volume":"150","author":"de Groot","year":"2009","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.clim.2019.108325_bb0330","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1136\/annrheumdis-2011-200477","article-title":"Pulse versus daily oral cyclophosphamide for induction of remission in ANCA-associated vasculitis: long-term follow-up","volume":"71","author":"Harper","year":"2012","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.clim.2019.108325_bb0335","doi-asserted-by":"crossref","first-page":"488","DOI":"10.7326\/0003-4819-116-6-488","article-title":"Wegener granulomatosis: an analysis of 158 patients","volume":"116","author":"Hoffman","year":"1992","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.clim.2019.108325_bb0340","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1056\/NEJMoa0909905","article-title":"Rituximab versus cyclophosphamide for ANCA-associated vasculitis","volume":"363","author":"Stone","year":"2010","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.clim.2019.108325_bb0345","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1186\/s12882-019-1226-0","article-title":"Intravenous pulse methylprednisolone for induction of remission in severe ANCA associated Vasculitis: a multi-center retrospective cohort study","volume":"20","author":"Chanouzas","year":"2019","journal-title":"BMC Nephrol."},{"key":"10.1016\/j.clim.2019.108325_bb0350","first-page":"260","article-title":"A novel glucocorticoid-free maintenance regimen for anti-neutrophil cytoplasm antibody-associated vasculitis","volume":"58","author":"Pepper","year":"2019","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.clim.2019.108325_bb0355","doi-asserted-by":"crossref","first-page":"2180","DOI":"10.1681\/ASN.2007010090","article-title":"Randomized trial of plasma exchange or high-dosage methylprednisolone as adjunctive therapy for severe renal vasculitis","volume":"18","author":"Jayne","year":"2007","journal-title":"J. Am. Soc. Nephrol."},{"issue":"Suppl. 10","key":"10.1016\/j.clim.2019.108325_bb0360","article-title":"The effects of plasma exchange and reduced-dose glucocorticoids during remission-induction for treatment of severe ANCA-associated vasculitis [abstract]","volume":"70","author":"Walsh","year":"2018","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.clim.2019.108325_bb0365","doi-asserted-by":"crossref","first-page":"2461","DOI":"10.1002\/art.21142","article-title":"Randomized trial of cyclophosphamide versus methotrexate for induction of remission in early systemic antineutrophil cytoplasmic antibody-associated vasculitis","volume":"52","author":"De Groot","year":"2005","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.clim.2019.108325_bb0370","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1136\/annrheumdis-2018-214245","article-title":"Mycophenolate mofetil versus cyclophosphamide for remission induction in ANCA-associated vasculitis: a randomised, non-inferiority trial","volume":"78","author":"Jones","year":"2019","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.clim.2019.108325_bb0375","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1002\/acr.20176","article-title":"Effects of duration of glucocorticoid therapy on relapse rate in antineutrophil cytoplasmic antibody-associated vasculitis: a meta-analysis","volume":"62","author":"Walsh","year":"2010","journal-title":"Arthritis Care Res."},{"key":"10.1016\/j.clim.2019.108325_bb0380","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.2215\/CJN.00100114","article-title":"Long-term follow-up of cyclophosphamide compared with azathioprine for initial maintenance therapy in ANCA-associated vasculitis","volume":"9","author":"Walsh","year":"2014","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"10.1016\/j.clim.2019.108325_bb0385","doi-asserted-by":"crossref","first-page":"2790","DOI":"10.1056\/NEJMoa0802311","article-title":"Azathioprine or methotrexate maintenance for ANCA-associated vasculitis","volume":"359","author":"Pagnoux","year":"2008","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.clim.2019.108325_bb0390","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1002\/art.39450","article-title":"Long-term outcomes among participants in the WEGENT trial of remission-maintenance therapy for granulomatosis with polyangiitis (Wegener's) or microscopic polyangiitis","volume":"68","author":"Puechal","year":"2016","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.clim.2019.108325_bb0395","doi-asserted-by":"crossref","first-page":"2381","DOI":"10.1001\/jama.2010.1658","article-title":"Mycophenolate mofetil vs azathioprine for remission maintenance in antineutrophil cytoplasmic antibody-associated vasculitis: a randomized controlled trial","volume":"304","author":"Hiemstra","year":"2010","journal-title":"JAMA"},{"key":"10.1016\/j.clim.2019.108325_bb0400","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1093\/rheumatology\/kem029","article-title":"Elevated relapse rate under oral methotrexate versus leflunomide for maintenance of remission in Wegener's granulomatosis","volume":"46","author":"Metzler","year":"2007","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.clim.2019.108325_bb0405","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1056\/NEJMoa1404231","article-title":"Rituximab versus azathioprine for maintenance in ANCA-associated vasculitis","volume":"371","author":"Guillevin","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.clim.2019.108325_bb0410","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1136\/annrheumdis-2017-212878","article-title":"Comparison of individually tailored versus fixed-schedule rituximab regimen to maintain ANCA-associated vasculitis remission: results of a multicentre, randomised controlled, phase III trial (MAINRITSAN2)","volume":"77","author":"Charles","year":"2018","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.clim.2019.108325_bb0415","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1002\/art.40802","article-title":"Efficacy and safety of belimumab and azathioprine for maintenance of remission in antineutrophil cytoplasmic antibody-associated vasculitis: a randomized controlled study","volume":"71","author":"Jayne","year":"2019","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.clim.2019.108325_bb0420","doi-asserted-by":"crossref","first-page":"71","DOI":"10.5527\/wjn.v7.i3.71","article-title":"Antineutrophil cytoplasmic antibody associated vasculitides with renal involvement: open challenges in the remission induction therapy","volume":"7","author":"Salvadori","year":"2018","journal-title":"World J. Nephrol."},{"key":"10.1016\/j.clim.2019.108325_bb0425","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/j.ejim.2015.04.022","article-title":"Eosinophilic granulomatosis with polyangiitis (Churg-Strauss) (EGPA) consensus task force recommendations for evaluation and management","volume":"26","author":"Groh","year":"2015","journal-title":"Eur. J. Intern. Med."},{"key":"10.1016\/j.clim.2019.108325_bb0430","doi-asserted-by":"crossref","first-page":"1921","DOI":"10.1056\/NEJMoa1702079","article-title":"Mepolizumab or placebo for eosinophilic granulomatosis with polyangiitis","volume":"376","author":"Wechsler","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.clim.2019.108325_bb0435","article-title":"Pediatric open-label clinical study of rituximab for the treatment of granulomatosis with polyangiitis (GPA) and microscopic polyangiitis (MPA) [abstract]","volume":"70","author":"Brogan","year":"2018","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.clim.2019.108325_bb0440","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.2215\/CJN.01210214","article-title":"The new histopathologic classification of ANCA-associated GN and its association with renal outcomes in childhood","volume":"9","author":"Noone","year":"2014","journal-title":"Clin. J. Am. Soc. Nephrol."}],"container-title":["Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521661619305376?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521661619305376?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T15:59:47Z","timestamp":1761494387000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521661619305376"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2]]},"references-count":88,"alternative-id":["S1521661619305376"],"URL":"https:\/\/doi.org\/10.1016\/j.clim.2019.108325","relation":{},"ISSN":["1521-6616"],"issn-type":[{"value":"1521-6616","type":"print"}],"subject":[],"published":{"date-parts":[[2020,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Childhood GPA, EGPA, and MPA","name":"articletitle","label":"Article Title"},{"value":"Clinical Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clim.2019.108325","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"108325"}}